Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Fixed Phage Limited currently maintains 2 pending office actions within the Chemistry & Materials technology area. These actions are distributed across 2 distinct examiners and 2 distinct art units, indicating a diversified prosecution presence within the USPTO. For a practitioner, this distribution requires a strategy that can adapt to the specific requirements of multiple administrative units. The presence of 2 distinct art units suggests that the company's intellectual property covers a range of technical sub-specialties within the broader technology area.
The busiest examiner for this portfolio is KITT, STEPHEN A, who is currently managing 1 busiest examiner pending action. This means that KITT, STEPHEN A is responsible for a portion of the company's active workload, while the remaining pending action is handled by another examiner. This split workload across 2 distinct examiners necessitates maintaining multiple lines of communication. Practitioners should tailor their approach to the individual tendencies of KITT, STEPHEN A while also addressing the requirements of the second examiner involved in the 2 pending office actions. This balanced distribution across 2 distinct art units requires careful coordination to ensure consistent legal positions.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| §112 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KITT, STEPHEN A | 1 | 54.7% | +38.7% |
| SALVOZA, M FRANCO G | 1 | 68.4% | +30.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17295414 | PRODUCTION OF IMMOBILISED BACTERIOPHAGE | SALVOZA, M FRANCO G | 42d overdue |
| 17602627 | CONTINUOUS TREATMENT WITH PLASMA | KITT, STEPHEN A | — |
| Art Unit | Apps |
|---|---|
| 1717 | 1 |
| 1672 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17602627 | CONTINUOUS TREATMENT WITH PLASMA | KITT, STEPHEN A | 1717 | §103 | Final Rejection | — | Pending | Oct 08, 2021 |
| 17295414 | PRODUCTION OF IMMOBILISED BACTERIOPHAGE | SALVOZA, M FRANCO G | 1672 | §112 | Non-Final OA | 42d overdue | Pending | May 19, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial